Ignite Creation Date:
2025-12-24 @ 5:57 PM
Ignite Modification Date:
2025-12-29 @ 1:56 PM
Study NCT ID:
NCT06223568
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2024-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-10
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-24
First Submit QC Date:
None
Study First Post Date:
2024-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-11
Last Update Post Date Type:
ESTIMATED